TOBRAMYCIN (Vantobra®)
Clinical Indication
Chronic pulmonary infection due to Pseudomonas aeruginosa
Comments
New formulation
Not yet reviewed
Date of classification
June 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.